Doxycycline with or without progestin for chronic endometritis in women with recurrent reproductive failure
Official title: Clinical Efficacy and Pregnancy Outcomes of Doxycycline Combined With Medroxyprogesterone Acetate Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF): A Prospective Randomized Controlled Trial
Run by Lanzhou University Second Hospital · NCT07488949 · Data updated 2026-11-12
This trial tests whether adding the progestin medroxyprogesterone acetate to doxycycline improves pregnancy outcomes for women with chronic endometritis and recurrent reproductive failure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 45 Years |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | Lanzhou University Second Hospital Academic / other |
| Locations | 1 site (Lanzhou, Gansu) |
| Status | Recruiting |
| Started | April 9, 2024 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2031 |
| Registry record updated | March 23, 2026 |
| Trial ID | NCT07488949 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women age 20–45 who have CD138-confirmed chronic endometritis, a diagnosis of recurrent reproductive failure, plan to conceive within 12 months, and have no contraindication to hysteroscopy or the study medications.
✕Probably not a fit
Women whose infertility is due to other causes such as uterine structural disease, active genital infection, male factor infertility, contraindications to the medications, pregnancy or lactation are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial assigns women aged 20–45 with CD138-confirmed chronic endometritis and recurrent reproductive failure to receive either doxycycline plus medroxyprogesterone acetate or doxycycline plus placebo. Participants must be planning to conceive within 12 months and will undergo hysteroscopy and endometrial biopsy at baseline. The study follows participants for reproductive outcomes including pregnancy, ongoing pregnancy, spontaneous miscarriage, and live birth. Safety and tolerability of the treatment regimens will also be monitored.
Why it matters
Potential benefit: If successful, adding MPA to doxycycline could increase pregnancy and live birth rates for women with chronic endometritis and recurrent reproductive failure.
How similar studies have gone: Antibiotic treatment for chronic endometritis has shown some success in improving reproductive outcomes, but combining doxycycline with a progestin like MPA is relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * women aged 20-45 years; * plans to conceive within 12 months; * chronic endometritis(CE) confirmed by endometrial CD138 immunohistochemistry (IHC); * a diagnosis of recurrent reproductive failure(RRF); * willingness to undergo hysteroscopy and endometrial biopsy; * no contraindications to the study medications. Exclusion Criteria: * acute genital tract infection, gynecologic malignancy, endometrial hyperplasia, or uterine fibroids; * pregnancy or lactation; * contraindications to hysteroscopy or anesthesia; * use of antibiotics, glucocorticoids, estrogens, or progestins within 3 months before trial initiation; * allergy to doxycycline or medroxyprogesterone acetate(MPA); * abnormal semen parameters in the male partner.
Where it's running
-
Lanzhou University Second Hospital
Lanzhou, Gansu, China Recruiting
Study contacts
- Principal investigator: Fang Wang — Lanzhou University Second Hospital
- Study coordinator: Fang Wang
- Email: ery_fwang@lzu.edu.cn
- Phone: 13919302888
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Berberine plus doxycycline versus doxycycline alone for chronic endometritis
This trial tests whether adding berberine to standard doxycycline helps women of childbearing age with chronic endometritis diagnosed by CD138 to become cured more often.
-
Fertility outcomes after antibiotic treatment in women with chronic endometritis
This study tests whether antibiotic therapy can improve fertility and pregnancy outcomes in women with chronic endometritis diagnosed during infertility workups.
-
The FLORA project: looking for endometrium microbes linked to chronic endometritis and pregnancy success
This study tests the relationship between the endometrial microbiome and chronic endometritis in women undergoing IVF/ICSI.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.